Improvement of abnormal saccadic eye movements in Huntington's disease by sulpiride: a case study.
Sulpiride treatment improved both the abnormal asymmetric saccadic eye movements (SEM) and the abnormal involuntary movements (AIMs) in a patient with Huntington's disease (HD). However, sulpiride corrected the abnormalities of SEM in the right, but not the left, hemi-field and the degeneration of the left striatal tissue was greater as visualised by the magnetic resonance imaging (MRI) scan.